| Product Name | NebuSelect™ Recombinant Human IGFII, hFc-tag |
|---|---|
| Catalog Number | NBL-241427 |
| Alias/Synonyms | IGFII |
| Appearance | see COA |
| Molecule Weight | |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | P01344-1 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-241427-100ug | 100ug | Inquire | Inquire | |
| NBL-241427-1mg | 1mg | Inquire | Inquire | |
| NBL-241427-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human IGFII, hFc-tag
Catalog#:
NBL-241427
Description:
NebuSelect™ Recombinant Human IGFII, hFc-tag(Cat#NBL-241427) is expressed in HEK293 with hFc tag at the N-Terminus.It contains Ala25-Glu91.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 33.00 kDa. Due to glycosylation, the protein migrates to 35-45 kDa based on Bis-Tris PAGE result.
Target Name:
IGFII
Target Information:
The insulin family consists of insulin, insulin-like growth factor 1 (IGF-1), insulin-like growth factor 2 (IGF-2), their receptors (IR, IGF-1R and IGF-2R), and their binding proteins. All three ligands are involved in cell proliferation, apoptosis, protein synthesis and metabolism due to their homologous sequences and structural similarities. Insulin-like growth factor 2, a member of the insulin family, plays an important role in embryonic development, metabolic disorders, and tumorigenesis by combining with three receptors with different degrees of affinity.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.